Solid result and some great data coming through. Tailwinds, momentum, etc.
I like the mention of 'pressing the advantage' in the webinar, and taking technological edge we have currently and driving hard with it. Marquee clients like ANZ case study will be helpful for this, and potential international expansion.
As much as the market is saying 'profitability is all we care about', big revenue growth is an undeniable aphrodisiac, and IMO we need to drive sales which seems to be on the menu. To that end, international markets are an obvious option, and if the 3rd party providers are multi-nationals with presence in Europe/UK then all the better to expand through known channels.
Do we have USA expansion options with the licence agreement with that other mob?
There's a lot to like about this business turnaround story. Wilted tech idealist meets hardened debt recovery business (with a velvet glove) in a cost of living crisis. The movie script writes itself!
- Forums
- ASX - By Stock
- CCR
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCR (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.0¢ |
Change
0.005(1.54%) |
Mkt cap ! $138.7M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 32.0¢ | $41.53K | 127.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 18458 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 0.320 |
1 | 20000 | 0.310 |
1 | 13436 | 0.305 |
1 | 10000 | 0.300 |
1 | 3448 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 96039 | 1 |
0.350 | 116234 | 2 |
0.365 | 17120 | 1 |
0.380 | 28985 | 1 |
0.390 | 14000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
CCR (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online